Survey Study: Financial Impact of Breast Cancer Treatment
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT03615573|
Recruitment Status : Active, not recruiting
First Posted : August 6, 2018
Last Update Posted : December 15, 2021
|Condition or disease||Intervention/treatment|
|Breast Cancer||Other: Quality of Life Surveys|
|Study Type :||Observational|
|Actual Enrollment :||103 participants|
|Official Title:||Determining the Financial Impact of Breast Cancer Treatment Over a One Year Period for Patients at a Rural Cancer Center|
|Actual Study Start Date :||September 4, 2018|
|Estimated Primary Completion Date :||November 30, 2022|
|Estimated Study Completion Date :||November 30, 2023|
- Other: Quality of Life Surveys
Patients with breast cancer diagnosis complete questionnaires over 20-30 minutes at baseline and at 3, 6, and 12 months after enrollment.
- Change in level of self-reported financial burden [ Time Frame: Baseline through 1 year ]Will evaluate the change in Comprehensive Score for Financial Toxicity (COST-FACIT) measurements from baseline to 1 year follow up. This survey consists of 14 questions related to finances.Responses include 5 options with lower scores representing worse outcomes. Scores at 1 year will be compared to baseline scores.
- Change in level of self-reported health insurance literacy [ Time Frame: Baseline through 1 year ]Will evaluate the change in Health Insurance Literacy Measurements (HILM) from baseline to 1 year follow up
- Self-reported access and utilization of institutional support services [ Time Frame: Baseline through 1 year ]Will evaluate reported access and utilization of institutional support services and its association to financial burden in the first 12 months after enrollment.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03615573
|United States, Pennsylvania|
|Guthrie Medical Group|
|Sayre, Pennsylvania, United States, 18840|
|Principal Investigator:||Cynthia Perry-Keaty, RN, MS, FNP-BC, AOCNP||The Guthrie Clinic|